Loughborough, United Kingdom

Peter Cage


Average Co-Inventor Count = 5.2

ph-index = 4

Forward Citations = 44(Granted Patents)


Company Filing History:


Years Active: 2005-2011

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Peter Cage

Introduction

Peter Cage is a notable inventor based in Loughborough, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that modulate chemokine activity. With a total of 4 patents to his name, Cage's work has the potential to impact therapeutic approaches for various conditions.

Latest Patents

Cage's latest patents include innovative compounds such as Piperidines as chemokine modulators (CCR). These compounds are designed to modulate chemokine activity, specifically targeting CCR3, which may be beneficial in treating asthma. Another patent focuses on compounds of formula (I), detailing a process for their preparation, pharmaceutical compositions containing them, and their therapeutic uses.

Career Highlights

Peter Cage is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to explore and develop groundbreaking pharmaceutical solutions. His contributions have been instrumental in advancing the company's research initiatives.

Collaborations

Cage has collaborated with esteemed colleagues such as Mark Furber and Christopher Luckhurst. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Peter Cage's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents and collaborations reflect a commitment to advancing medical science and improving patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…